Cardiovascular Innovation Institute
A Partnership of Medical Excellence
Jewish Hospital has always believed that medical advancement and growth is not achieved through singularity, but through partnerships with those who specialize in the research and development of medical innovations and technology. Out of this belief, the Cardiovascular Innovation Institute (CII) was born.
The Cardiovascular Innovation Institute is a progressive collaboration between the University of Louisville and Jewish Hospital & St. Mary’s HealthCare. Support also comes from Kosair Charities, the Kentucky Cabinet for Economic Development and the Department of Commercialization and Innovation, the Gheens Foundation and federal appropriations secured by the efforts of Senator Mitch McConnell.
The Institute was specifically created to bring new treatments for cardiovascular disease from the laboratory bench to the patient bedside, improving patient lives through world-class cardiovascular research and scientific discovery.
The vision of CII, as seen by Dr. Laman Gray, who serves as medical director, was to create an international research institute focused on combating heart disease and driven to be the medical community’s partner of choice for developing, testing and commercializing breakthrough innovations.
Dr. Gray, along with Stuart K. Williams, Ph.D., CII scientific director, and Mark Slaughter, M.D., director of the Heart Transplant and Mechanical Assist Device Program at Jewish Hospital and Chief of the Department of Thoracic and Cardiovascular Surgery for the University of Louisville, are making this vision a reality by developing cutting edge cardiovascular technologies aimed at cardiac regeneration.
Dr. Gray served at Jewish Hospital for many years as head of the heart program. He is an internationally recognized leader in the fields of cardiac surgery, artificial hearts and circulatory support systems. Dr. Gray’s proud history includes performing Kentucky’s first adult heart transplant and the world’s first and second AbioCor® totally implantable artificial heart procedures.
Dr. Williams is an established academic and industry leader in numerous areas ranging from biomedical devices to regenerative medicine to vascular therapeutics. He brings substantial experience of developing intellectual property, with numerous pending patents, as well as translating basic scientific research into useful applications in the medical field.
Dr. Slaughter is an internationally acclaimed expert in heart transplants and ventricular assist devices (VAD). The overlying goal for Dr. Slaughter and his team is to offer individuals with heart failure alternatives to heart transplantation so if their own heart can recover, they can heal without the need of a transplant.
In addition to Drs. Gray, Slaughter and Williams, there are 10 researchers working at CII to improve the quality of life for heart failure patients through the development of bio-adaptive heart devices, new technologies for ventricular assist devices, artificial hearts and combination therapies.
This exciting, ground breaking research will not only make a substantial difference in what we do at Jewish Hospital, but how heart care will advance worldwide – and it’s all happening at the Cardiovascular Innovation Institute in Louisville, Kentucky.
For more information about CII, please click here. Patients or physicians interested in learning more about Jewish Hospital Heart Care can call (502) 587-4252.